{
  "ticker": "SYRE",
  "company_name": "Spyre Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06448247",
      "title": "A Study of SPY001-001 in Healthy Volunteers",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2024-06-06",
      "completion_date": "2026-05-05",
      "enrollment": 0,
      "sponsor": "Spyre Therapeutics, Inc."
    },
    {
      "nct_id": "NCT07012395",
      "title": "A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative",
      "start_date": "2025-05-27",
      "completion_date": "2028-03",
      "enrollment": 0,
      "sponsor": "Spyre Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06873724",
      "title": "SPY003-207 in Healthy Volunteers",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2025-03-10",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "Spyre Therapeutics, Inc."
    },
    {
      "nct_id": "NCT07148414",
      "title": "A Study of SPY072 in Rheumatic Disease",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Rheumatic Diseases, Rheumatic Joint Disease, PsA (Psoriatic Arthritis), AxSpA, Rheumatologic Disease",
      "start_date": "2025-08-21",
      "completion_date": "2028-03-31",
      "enrollment": 0,
      "sponsor": "Spyre Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06622070",
      "title": "A Study of SPY002-072 in Healthy Volunteers",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2024-11-18",
      "completion_date": "2026-08-08",
      "enrollment": 0,
      "sponsor": "Spyre Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06672718",
      "title": "A Study of SPY002-091 in Healthy Volunteers",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2024-11-26",
      "completion_date": "2026-06-22",
      "enrollment": 0,
      "sponsor": "Spyre Therapeutics, Inc."
    }
  ],
  "summary": {
    "total_trials": 6,
    "by_phase": {
      "PHASE1": 4,
      "PHASE2": 2
    },
    "by_status": {
      "ACTIVE_NOT_RECRUITING": 1,
      "RECRUITING": 5
    },
    "active_trials": 6,
    "completed_trials": 0,
    "conditions": [
      "Healthy",
      "Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Rheumatic Diseases, Rheumatic Joint Disease, PsA (Psoriatic Arthritis), AxSpA, Rheumatologic Disease",
      "Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:22:13.254221",
    "search_query": "Spyre Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Spyre+Therapeutics,+Inc."
  }
}